IMCR Live signaler | Maksimer profitt med Getagraph.com

KJøP 107457 min ago

@ $71.91

Utstedt: 14 feb 2024 @ 21:47

Avkastning: -18.70%

Forrige signal: feb 14 - 15:30

Forrige signal: Selg

Avkastning: -2.49 %

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 22:00):

Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases...

Stats
Dagens volum	403 551
Gjennomsnittsvolum	512 688
Markedsverdi	2.91B
EPS	$0 ( 2024-02-28 )
Neste inntjeningsdato	( $-0.320 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-41.17
ATR14	$0.0510 (0.09%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	St Leger Tina Amber	Sell	4 375	Employee Share Option (Right to Buy)
2024-04-01	St Leger Tina Amber	Buy	4 375	Ordinary Shares
2024-04-01	St Leger Tina Amber	Sell	4 375	Ordinary Shares
2024-02-28	Berman David M	Sell	36 509	Employee Share Option (Right to Buy)
2024-02-28	Berman David M	Buy	36 509	Ordinary Shares

INSIDER POWER
-75.94
Last 63 transactions
Buy: 607 651 \| Sell: 4 752 433

Volum Korrelasjon

Lang: 0.49 (neutral)

Kort: 0.68 (moderate)

Signal:(74.516) Neutral

Immunocore Holdings plc Korrelasjon

10 Mest positive korrelasjoner
AMRB	0.859
LWAC	0.837
MMAC	0.835

10 Mest negative korrelasjoner
SVAC	-0.83
TLGT	-0.821

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Immunocore Holdings plc Korrelasjon - Valuta/Råvare

0.62
( weak )

0.55
( weak )

0.00
( neutral )

0.62
( weak )

-0.47
( neutral )

-0.56
( weak negative )

Immunocore Holdings plc Økonomi

Annual	2023
Omsetning:	$249.43M
Bruttogevinst:	$248.39M (99.58 %)
EPS:	$-0.00110

FY	2023
Omsetning:	$249.43M
Bruttogevinst:	$248.39M (99.58 %)
EPS:	$-0.00110

FY	2022
Omsetning:	$143.74M
Bruttogevinst:	$143.28M (99.68 %)
EPS:	$-0.900

FY	2021
Omsetning:	$26.52M
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-3.10

Financial Reports:

No articles found.

Immunocore Holdings plc

Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in Phase I/II dose escalation trial in patients with solid tumor cancers, including non-small-cell lung (NSCLC), gastric, head and neck, ovarian, and synovial sarcoma cancers; IMC-F106C, which is in a Phase I/II dose escalation trial in patients with multiple solid tumor cancers comprising NSCLC, small-cell lung, endometrial, ovarian, cutaneous melanoma, and breast cancers. In addition, the company's programs for infectious diseases include IMC-I109V, which is in a Phase I/II clinical trial in patients with chronic hepatitis B virus; and IMC-M113V that is in pre-clinical development stage for patients with human immunosuppression virus. Further, it develops product candidates to provide precision targeted immunosuppression for the treatment of autoimmune diseases. Immunocore Holdings plc was founded in 1999 and is headquartered in Abingdon, the United Kingdom.